share_log

康希諾生物:股份發行人的證券變動月報表

CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities

HKEX ·  Oct 7 16:26

Summary by Moomoo AI

康希諾生物股份公司(康希诺生物)於2024年10月7日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年9月30日的股份變動情況。報告顯示,康希諾生物的H股(股份代號06185)和A股(股份代號688185)在報告期內的已發行股份數量均無變動,H股和A股的已發行股份數目分別維持在132,670,900股和114,778,999股。此外,公司未進行任何股份的回購或購回活動,庫存股份數量亦維持在零。公司先前於2022年1月23日宣布的員工持股計劃或股權激勵計劃下的A股回購方案,截至2024年9月30日,已回購406,098股A股,但未進行注銷。本月報表中未提及有關香港預託證券的資料。
康希諾生物股份公司(康希诺生物)於2024年10月7日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年9月30日的股份變動情況。報告顯示,康希諾生物的H股(股份代號06185)和A股(股份代號688185)在報告期內的已發行股份數量均無變動,H股和A股的已發行股份數目分別維持在132,670,900股和114,778,999股。此外,公司未進行任何股份的回購或購回活動,庫存股份數量亦維持在零。公司先前於2022年1月23日宣布的員工持股計劃或股權激勵計劃下的A股回購方案,截至2024年9月30日,已回購406,098股A股,但未進行注銷。本月報表中未提及有關香港預託證券的資料。
Cansinobio submitted the latest monthly report on securities changes to The Stock Exchange of Hong Kong Limited on October 7, 2024, reporting the share changes as of September 30, 2024. The report shows that the number of issued shares of H shares (stock code 06185) and A shares (stock code 688185) of Cansinobio remained unchanged during the reporting period, with the number of issued shares of H shares and A shares maintained at 132,670,900 shares and 114,778,999 shares respectively. In addition, the company did not engage in any share repurchase or buyback activities, and the inventory of shares also remained at zero. As of September 30, 2024, the company had repurchased 406,098 A shares under the A share repurchase program for employee shareholding or stock-based incentives announced on January 23, 2022, but had not cancelled them. There is no mention of information regarding Hong Kong depositary securities in this month's report.
Cansinobio submitted the latest monthly report on securities changes to The Stock Exchange of Hong Kong Limited on October 7, 2024, reporting the share changes as of September 30, 2024. The report shows that the number of issued shares of H shares (stock code 06185) and A shares (stock code 688185) of Cansinobio remained unchanged during the reporting period, with the number of issued shares of H shares and A shares maintained at 132,670,900 shares and 114,778,999 shares respectively. In addition, the company did not engage in any share repurchase or buyback activities, and the inventory of shares also remained at zero. As of September 30, 2024, the company had repurchased 406,098 A shares under the A share repurchase program for employee shareholding or stock-based incentives announced on January 23, 2022, but had not cancelled them. There is no mention of information regarding Hong Kong depositary securities in this month's report.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more